SRI-22818

Overview

SRI-22818 is a NF-κB activator with an EC 50 of 0.5 μM. SRI-22818 upregulates the expression of NF-κB and promotes its activation. SRI-22818 increases the level of SOD2 . SRI-22818 exhibits activity in the SOD1 G93A model of amyotrophic lateral sclerosis (ALS). SRI-22818 can be used for research related to amyotrophic lateral sclerosis.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Amyotrophic Lateral Sclerosis | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > SOD

Product Information

• Catalog No.: HY-182446
• CAS No.: 1429221-68-0
• Molecular Formula: C16H12BrNO3
• Molecular Weight: 346.18
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source